A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects
Clinical trial NCT06501534 · COMPLETED
Trial details
- NCT number
- NCT06501534
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2024-12-13
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.